| ▲ | prism56 11 hours ago | |
The article doesn't really explore the reasons why for this quote: > Our concern with the current state of obesity treatment is that the marketing of GLP-1 medications and their massive popularity is overshadowing scientific evidence supporting metabolic and bariatric surgery as the most efficacious therapy for obesity,” lead study author Tyler Cohn, a surgeon and associate professor at Loyola University Medical Center, told Gizmodo. That seems surprising for me, my Intution says surely surgery would be a last resut before trying ozempic? | ||
| ▲ | quickthrowman 10 hours ago | parent | next [-] | |
> That seems surprising for me, my Intution says surely surgery would be a last resut before trying ozempic? > lead study author Tyler Cohn, a surgeon If I asked a surgeon whether ozempic or bariatric surgery was a better option for treating obesity, I’d expect them to recommend surgery. If you ask a doctor that prescribes ozempic, I’d expect them to recommend ozempic. | ||
| ▲ | BizarroLand 10 hours ago | parent | prev [-] | |
I would say the other way around, that GLP-1 should be tried before surgery. | ||